Merck nearing deal for Cidara, FT reports
Reuters· 2025-11-13 23:53
Merck is closing in on a deal to buy Cidara Therapeutics in a deal valuing the biotechnology company at a premium to its $3.3 billion market capitalization, the Financial Times reported on Thursday. ...
Viasat Successfully Tests HaloNet Launch Telemetry Solution for NASA Onboard Blue Origin's New Glenn
Globenewswire· 2025-11-13 23:53
Core Insights - Viasat Inc. successfully executed its first flight test of a launch telemetry data relay service on Blue Origin's New Glenn rocket, marking a significant milestone in its partnership with NASA [1][3][6] - The demonstration is part of NASA's Communications Services Project, aimed at developing commercial satellite relay communications services to support future science missions as NASA phases out its Tracking and Data Relay Satellite fleet [2][5] Viasat's Launch Telemetry Data Relay Service - The HaloNet launch data relay solution provides continuous, real-time data transmission during launch operations, utilizing Viasat's global L-band satellite network and geostationary satellites [4][5] - During the initial demonstration, a persistent connection was established, allowing flight data to be transmitted to the launch operations center for processing [4][5] Future Plans and Collaborations - Viasat plans additional solution demonstrations as part of its partnership with NASA, with a second demonstration mission with Blue Origin anticipated for early next calendar year [5][6] - The company aims to validate how commercial technology can support both NASA and other launch providers in future missions [3][5]
BioAtla, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:BCAB) 2025-11-13
Seeking Alpha· 2025-11-13 23:52
To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
BioAtla outlines $800M peak sales target for Oz-V as FDA alignment paves way for phase III launch (NASDAQ:BCAB)
Seeking Alpha· 2025-11-13 23:52
To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Fidelity National Information Services, Inc. (FIS) Presents at KBW Fintech Payments Conference 2025 Transcript
Seeking Alpha· 2025-11-13 23:51
Core Insights - The CEO of FIS, Stephanie Ferris, has highlighted significant accomplishments over the past three years, including the separation from Worldpay and a strategic realignment for future growth [1][2] - The company is optimistic about its position in the fintech sector, emphasizing the foundational work done that will support advancements in technologies such as AI and tokenized deposits as it moves towards 2026 and beyond [2] Company Developments - FIS has successfully completed the separation from Worldpay, which is a major milestone for the company [1] - The company is focusing on infrastructure improvements and strategic initiatives that will enable it to leverage advanced technologies in the future [2] Industry Outlook - The fintech industry is experiencing a transformative period, with companies like FIS preparing to adopt scaled technologies that will enhance their service offerings [2] - There is a strong emphasis on innovation within the industry, particularly in areas such as artificial intelligence and digital financial solutions [2]
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Lags Revenue Estimates
ZACKS· 2025-11-13 23:51
分组1 - BioHarvest Sciences Inc. reported a quarterly loss of $0.14 per share, which is an improvement from a loss of $0.16 per share a year ago, aligning with the Zacks Consensus Estimate [1] - The company posted revenues of $9.07 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.74%, but showing an increase from $6.54 million year-over-year [2] - The stock has increased approximately 27.8% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [3] 分组2 - The earnings outlook for BioHarvest Sciences Inc. is uncertain, with current consensus EPS estimates at -$0.09 for the coming quarter and -$0.59 for the current fiscal year [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is in the top 35% of over 250 Zacks industries, indicating a favorable industry outlook [8] - The estimate revisions trend for BioHarvest Sciences Inc. was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it will perform in line with the market [6]
GameSquare Holdings, Inc. (GAME) Reports Q3 Loss, Misses Revenue Estimates
ZACKS· 2025-11-13 23:51
GameSquare Holdings, Inc. (GAME) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.1 per share when it actually produced a loss of $0.11, delivering a surprise of -10%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.GameSquare Holdings, Inc., which ...
Super League Enterprise (SLE) Reports Q3 Loss, Misses Revenue Estimates
ZACKS· 2025-11-13 23:51
Super League Enterprise (SLE) came out with a quarterly loss of $2.3 per share versus the Zacks Consensus Estimate of a loss of $2.83. This compares to a loss of $21.6 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.73%. A quarter ago, it was expected that this company would post a loss of $6.8 per share when it actually produced a loss of $4.52, delivering a surprise of +33.53%.Over the last four quarters, the company has ...
Research Solutions Inc. (RSSS) Meets Q1 Earnings Estimates
ZACKS· 2025-11-13 23:51
Research Solutions Inc. (RSSS) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced earnings of $0.07, delivering a surprise of +75%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Research Solutions, whi ...
Gold Edges Higher on Possible Dip-Buying
WSJ· 2025-11-13 23:51
Gold edged higher in the early Asian session on possible dip-buying after likely profit-taking. ...